Anastrozole
We’ve already seen the positive effect anastrozole can have in treating the disease when it has been detected in post-menopausal women and now we can use it to stop it developing at all in some women - Will Quince

image by: HWN
HWN Suggests
Anastrozole: A Promising Breakthrough in Preventing Breast Cancer
The licensing of anastrozole as a preventive measure for breast cancer is a key moment in the fight against this formidable disease. With its proven effectiveness in reducing the risk of breast cancer in postmenopausal women, anastrozole has the potential to save thousands of lives and critical healthcare resources. Anastrozole serves as a great example of how the repurposing of existing medications can yield breakthroughs in healthcare, providing new hope to women at an increased risk of breast cancer and reinforcing the commitment to using innovation to improve our health service.Featured
A milestone in the history of medicine: Anastrazole
Anastrazole - a drug to be taken by cancer-free women to reduce the probability of developing breast cancer. This is a milestone in the pharmacological prevention of cancer, and we welcome the new approval of anastrozole. The new indication for the drug is for cancer-free women who have moderate to high risk for developing breast cancer, for example, have a relative who had breast cancer. This will offer reassurance to many women at moderate to high risk of the disease. Anastrozole is an aromatase inhibitor, which works by reducing oestrogen production by the body. The regulatory authority (MHRA) weighed the benefit/risk balance very carefully and found it to be favourable for this indication.
The U.K. just cleared a drug to prevent breast cancer. U.S. women may not know it’s already an option
The news that the U.K. has approved a preventive drug for post-menopausal women at risk of developing breast cancer wasn’t a shock to breast medical oncologist Abenaa Brewster. But the fact that a patient in her breast cancer prevention clinic hadn’t ever heard of such a possibility before was. “I thought to myself, ‘Oh, my God, I can’t believe a woman in America is being educated about preventive therapy from European use,’ because for the last 25 years in America, we have had two drugs that are FDA approved to be used for women who are at high risk of developing breast cancer to prevent breast cancer,” said Brewster, a professor of clinical cancer prevention at MD Anderson Cancer Center.
Articles of Interest
10 Years of Arimidex Reduces Recurrence Risk, But Doesn’t Improve Overall Survival
“Continuing adjuvant anastrozole for an additional five years after five years of initial treatment with anastrozole or tamoxifen followed by anastrozole was well tolerated and improved [disease-free survival],” the researchers concluded. “Although no difference in overall survival was observed as in other trials, extended anastrozole therapy could be one treatment choice in post-menopausal patients with hormone receptor-positive breast cancer.”
A new way to prevent breast cancer: anastrozole
First though, let’s look at how anastrozole works. The hormone oestrogen fuels the growth of many breast cancers. After women go through the menopause, their oestrogen is no longer produced by the ovaries – instead it’s made by an enzyme called aromatase. Aromatase is found in fatty tissues (such as the breasts), muscle and the skin. Anastrozole is a type of drug called an aromatase inhibitor. It blocks the action of aromatase and so lowers the amount of oestrogen in post-menopausal women.
Anastrozole Versus Tamoxifen as First-Line Therapy for Advanced Breast Cancer...
Anastrozole satisfied the predefined criteria for equivalence to tamoxifen. Together with the lower observed incidence of thromboembolic events and vaginal bleeding, these findings indicate that anastrozole should be considered as first-line therapy for postmenopausal women with ABC.
Anastrozole: the daily breast cancer pill tipped to save thousands of lives
Existing treatment approved for preventative use under 'pioneering' NHS drug repurposing scheme.
Anastrozole: Thousands to be offered drug to prevent breast cancer in England
Anastrozole, used for many years to treat the disease, has now been licensed as a preventative option. Recent trials show the drug can reduce the incidence of breast cancer by almost 50% in post-menopausal women at moderate or high risk of the disease. Charities said it was "a major step forward" for women with a significant family history of the cancer.
Continuous Anastrozole May Improve Survival in Postmenopausal Breast Cancer
Extending treatment with adjuvant anastrozole (Arimidex) for an additional 5 years among disease-free patients with postmenopausal hormone receptor (HR)–positive breast cancer tolerably improved some survival outcomes, according to findings from the phase 3 AERAS study published in the Journal of Clinical Oncology.
Drug that can halve breast cancer risk offered to 289,000 women in England
The drug, anastrozole, is being made available to women who are in greater danger because they have been through menopause and have a major family history of Britain’s commonest form of cancer. It displays “remarkable” potential to reduce the number of people who go on to develop the disease, the head of the NHS said last night.
Is Anastrozole the New Wonder Drug? - with Dr Tasha
In this video, I am going to talk about the drug Anastrozole which in this month has been licensed to be used as a preventative drug to prevent breast cancer. But hold on! That name kind of sounds similar. Well its right! While Anastrozole has been used for over 20 years in the treatment of breast cancer. It is usually prescribed to postmenopausal women who have been diagnosed with a hormone sensitive breast cancer.
Repurposed breast cancer drug could cut future cases by almost half
Scientists have found that as well as treating breast cancer, anastrozole – a hormone therapy – can also prevent cases. And the protective effect lasts for years after a woman has stopped taking the drug, officials said.
“Keeping the Boogie Man Away”: Medication Self-Management among Women Receiving Anastrozole Therapy
The oral hormonal agent anastrozole improves clinical outcomes for women with breast cancer, but women have difficulty taking it for the five-year course. The unique medication-taking experiences related to self-management of anastrozole therapy for women with early stage breast cancer are not known. Our purpose was to describe the medication-taking experiences for postmenopausal women with early stage breast cancer who were prescribed a course of anastrozole therapy.
Resources
Arimidex
ARIMIDEX 1 mg is a prescription hormonal treatment that helps fight breast cancer by lowering the amount of estrogen in the body. ARIMIDEX is a selective, non-steroidal aromatase inhibitor, which signifcantly lowers serum estradiol (estrogen) concentrations, without interfering with the formation of adrenal corticosteroids or aldosterone.
Cancer Research UK
Women with breast cancer usually only have anastrozole when they are post menopausal. Less often, some women who have not been through the menopause may also have anastrozole. In this instance, they have it in combination with other treatments that stop the ovaries working.
ChemoCare
ANASTROZOLE (an AS troe zole) treats breast cancer. It works by decreasing the amount of estrogen hormone your body makes, which slows or stops breast cancer cells from spreading or growing.

